{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:19Z","timestamp":1786119679997,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/mjt.0b013e3182068d91","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:17:01Z","timestamp":1297394221000},"page":"397-402","source":"Crossref","is-referenced-by-count":3,"title":["Impact of an Acute Coronary Syndrome Pathway in Achieving Target Heart Rate and Utilization of Evidence-Based Doses of Beta-Blockers"],"prefix":"10.1097","volume":"19","author":[{"given":"Farzan","family":"Irani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Herial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Colyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","first-page":"378","article-title":"Tran M, et al..","volume":"158","author":"Herman","year":"2009","journal-title":"Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target Am Heart J"},{"key":"R2-3-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial.","volume":"6","year":"1985","journal-title":"Eur Heart J"},{"key":"R3-3-20210202","first-page":"57","article-title":"16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":". Beta blockade during and after myocardial infarction: an overview of the randomized trials.","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"R5-3-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjmed.2007.04.016","article-title":". Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.","volume":"120","author":"Miller","year":"2007","journal-title":"Am J Med"},{"key":"R6-3-20210202","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.jacc.2004.07.014","article-title":". ACCAHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of CardiologyAmerican Heart Association Task Force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2006.01.004","article-title":"Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations.","volume":"7","author":"Fonarow","year":"2006","journal-title":"Rev Cardiovasc Med"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.287.10.1269","article-title":". Improving quality of care for acute myocardial infarction: the guidelines applied in practice (GAP) initiative.","volume":"287","author":"Mehta","year":"2002","journal-title":"JAMA"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":". Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.","volume":"25","author":"Viskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R12-3-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-6143.2003.08062.x","article-title":". Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport trials.","volume":"16","author":"Ellis","year":"2003","journal-title":"J Interv Cardiol"},{"key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0002-9149(03)00276-5","article-title":". Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.","volume":"91","author":"Biviano","year":"2003","journal-title":"Am J Cardiol"},{"key":"R14-3-20210202","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction.","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R15-3-20210202","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1345\/aph.18395","article-title":"Prevention of suboptimal beta-blocker treatment in patients with myocardial infarction.","volume":"33","author":"White","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/ajhp\/60.23.2471","article-title":"Dosage of beta-adrenergic blockers after myocardial infarction.","volume":"60","author":"Anderson","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"R17-3-20210202","first-page":"618","article-title":"Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group.","volume":"320","year":"1989","journal-title":"N Engl J Med"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0735-1097(02)02379-3","article-title":". Outpatient adherence to beta-blocker therapy after acute myocardial infarction.","volume":"40","author":"Butler","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":". Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3182068d91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:53:20Z","timestamp":1786042400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201211000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182068d91","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}